On Tuesday, Kite Pharma Inc (NASDAQ:KITE)’s shares inclined 1.56% to $55.32.
Kite Pharma Inc (KITE) declared clinical biomarker data from patients with relapsed/refractory B cell malignancies treated with anti-CD19 chimeric antigen receptor (CAR) T-cell therapy in a poster presentation during the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO), which is taking place in Chicago. In an ongoing Phase 1 clinical trial at the National Cancer Institute (NCI), being conducted under a Cooperative Research and Development Agreement (CRADA) between Kite Pharma and the NCI, patients with diverse B cell tumors are conditioned with cyclophosphamide and fludarabine, then dosed with their own T cells genetically modified to express a CAR designed to target the antigen CD19, a protein expressed on the cell surface of B-cell lymphomas and leukemias. As stated at last year’s ASCO meeting, 76% of evaluable patients (N=29) achieved an overall response rate in this study. In this updated biomarker analysis, conditioning chemotherapy was associated with a noteworthyrise in homeostatic cytokines and chemokines, which could favor expansion, activation, and trafficking of CAR T cells. In addition, the recovery of B cells was seen in 7 of 12 patients with ongoing response duration greater than 12 months.
Kite Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel cancer immunotherapy products. The company is developing a pipeline of engineered autologous cell therapy-based product candidates for the treatment of solid and hematological malignancies. Its lead product candidate is KTE-C19, a chimeric antigen receptors (CAR)-based therapy that is in Phase 1-2a clinical trials for the treatment of patients with refractory diffuse large B cell lymphoma.
PG&E Corporation (NYSE:PCG)’s shares dropped -1.42% to $52.90.
PG&E Corporation (PCG) and Electric Co. (PG&E) has been recognized by CIO magazine as one of the CIO 100 Award winners for its work in emergency response. The 28th annual award program recognizes organizations around the world that exemplify the highest level of operational and planned excellence in information technology (IT). PG&E was recognized for its innovative use of technologies that support the company’s emergency response base camps. The company is the only combined gas and electric utility on this year’s list and is one of several Bay Area organizations recognized.
PG&E Corporation, through its partner, Pacific Gas and Electric Company, transmits, delivers, and sells electricity and natural gas to residential, commercial, industrial, and agricultural customers primarily in northern and central California.
At the end of Tuesday’s trade, Raytheon Company (NYSE:RTN)‘s shares dipped -0.70% to $102.79.
Raytheon Company (RTN) secured the competitively-awarded second increment of the Defense Threat Reduction Agency (DTRA) maritime border security contract for the Republic of the Philippines. Under the $25 million contract, Raytheon will deliver sensing, command and control, and communications systems together with the training and sustainment services necessary to operationalize maritime border security capabilities.
Specific work planned under the increment II contract comprises:
- Installation of a common operating picture platform in the National Coast Watch Control (NCWC) and National Coast Watch Stations in two different Philippine provinces
- Design, installation and testing of electro/optical infrared cameras
- Continued integration of command, control, and communications equipment and infrastructure
- Construction of a training center
- Communications and surveillance upgrades to Philippine Coast Guard vessels
- Sustainment, training, and transition of capabilities to the government of the Philippines
Raytheon Company develops integrated products, services, and solutions in the areas of sensing; effects; command, control, communications, and intelligence; mission support; and cyber and information security worldwide. It operates in four segments: Integrated Defense Systems (IDS); Intelligence, Information, and Services (IIS); Missile Systems (MS); and Space and Airborne Systems (SAS).
Scorpio Tankers Inc. (NYSE:STNG), ended its Tuesday’s trading session with 2.47% gain, and closed at $9.55.
Scorpio Tankers Inc. (STNG) declared (i) a new $250 million Securities Buyback Program, (ii) that it has recently taken delivery of an MR product tanker and (iii) that it will not exercise the options to purchase two LR2s presently under construction (with deliveries predictable in the fourth quarter of 2016 and first quarter of 2017) from Scorpio Bulkers Inc., a related party.
Scorpio Tankers Inc., together with its auxiliaries, engages in the seaborne transportation of refined petroleum products and crude oil worldwide. As of March 31, 2015, it owned 67 tankers comprising 11 LR2 tanker, 2 LR1 tankers, 15 Handymax tankers, 39 MR tankers with an average age of 1.1 years; and time charters-in 20 product tankers, counting 5 LR2, 5 LR1, 3 MR, and 7 Handymax tankers. The company was founded in 2009 and is based in Monaco, Monaco.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
